Kellie Combs Presents at Digital Health Technology and Regulation Conference

Practices: Life Sciences, FDA Regulatory, Digital Health

Life sciences regulatory & compliance partner Kellie Combs (Washington, D.C.) will present at the Food and Drug Law Institute’s conference “Digital Health Technology and Regulation During COVID-19 and Beyond” on September 10. The virtual event will focus on digital health regulation and enforcement policies and exemptions the U.S. Food and Drug Administration has recently implemented.

Kellie’s panel “Regulation of Digital Health During and After COVID-19” will compare the traditional approval pathways available for software-as-medical device products and address the impact of increased funding for telehealth and remote patient monitoring tools under the CARES Act.

Cookie Settings